Cargando…
Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
The rare and heterogeneous kidney disorder C3 glomerulopathy (C3G) is characterized by dysregulation of the alternative pathway (AP) of the complement system. C3G is often associated with autoantibodies stabilizing the AP C3 convertase named C3 nephritic factors (C3NeF). The role of classical pathwa...
Autores principales: | Michels, Marloes A. H. M., van de Kar, Nicole C. A. J., van Kraaij, Sanne A. W., Sarlea, Sebastian A., Gracchi, Valentina, Engels, Flore A. P. T., Dorresteijn, Eiske M., van der Deure, Johannes, Duineveld, Caroline, Wetzels, Jack F. M., van den Heuvel, Lambertus P. W. J., Volokhina, Elena B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386118/ https://www.ncbi.nlm.nih.gov/pubmed/34456924 http://dx.doi.org/10.3389/fimmu.2021.715704 |
Ejemplares similares
-
Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort
por: Michels, Marloes A. H. M., et al.
Publicado: (2021) -
Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies
por: Rudnicki, Michael
Publicado: (2017) -
Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy
por: Michels, Marloes A. H. M., et al.
Publicado: (2019) -
Long-Term Outcomes of C3 Glomerulopathy and Immune-Complex Membranoproliferative Glomerulonephritis in Children
por: Kirpalani, Amrit, et al.
Publicado: (2020) -
Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy
por: Kovala, Marja, et al.
Publicado: (2023)